These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 580517)

  • 1. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.
    Lehtovirta P; Ranta T; Seppälä M
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):682-6. PubMed ID: 580517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.
    Friesen HG; Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():91S-99S. PubMed ID: 617073
    [No Abstract]   [Full Text] [Related]  

  • 5. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].
    Nillius SJ; Skarin O
    Lakartidningen; 1977 Nov; 74(46):4110-2. PubMed ID: 926944
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffectiveness of pyridoxine in evaluation and treatment of the hyperprolactinemic amenorrhea-galactorrhea syndrome.
    Goodenow TJ; Malarkey WB
    Am J Obstet Gynecol; 1979 Jan; 133(2):161-4. PubMed ID: 570356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].
    Hartemann P; Leclere J; Groussin M; Valdenaire JC; Maureira JJ; Belleville F; Nabet P
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):537-46. PubMed ID: 915214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of amenorrhoea, galactorrhoea and hypogonadism with bromocriptine.
    Donald RA; Espiner EA; Livesey JH
    Aust N Z J Med; 1978 Jun; 8(3):262-6. PubMed ID: 279321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Longtime study on bromoergocryptine therapy and pyridoxine therapy of amenorrhea-galactorrhea].
    Schindler AE; Plieninger M; Zubke W; Göser R; Keller E
    Arch Gynecol; 1979 Jul; 228(1-4):596. PubMed ID: 573598
    [No Abstract]   [Full Text] [Related]  

  • 14. Raised serum PRL and androgen levels associated with hyrsutism, amenorrhoea and galactorrhoea.
    Malato M
    Acta Eur Fertil; 1978 Dec; 9(4):175-83. PubMed ID: 573041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes.
    Kidd GS; Dimond R; Kark JA; Whorton N; Vigersky RA
    J Clin Endocrinol Metab; 1982 Apr; 54(4):872-5. PubMed ID: 6801073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of secondary amenorrhoea.
    Seppalå M; Hirvonen E; Ranta T
    Lancet; 1976 May; 1(7970):1154-6. PubMed ID: 58200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
    Wortsman J; Soler NG; Hirschowitz J
    Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients].
    Fossati P; Strauch G; Tourniaire J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1687-91. PubMed ID: 986640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.